GOLDAN KEITH A. (Chief Financial Officer) reported 1 transaction at SYNDAX PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 12/1/2025ACC: 0001193125-25-303941
Officer· Chief Financial Officer
Since Jun 2022
-1.22K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.22K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.22K
Price / share
—
Trade value
—
% of position
1.3%
12/1/2025
93.68K→92.45K
Total
Net shares
−1.22K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | G · Gift | −1.22K | — | — | 1.3% | 93.68K | 92.45K |
| Total | −1.22K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported